Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:55:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.4.2) was added to the record history, and the notice about government funding lapse as well as the previous revision (v3.4.1) were removed.
    Difference
    0.9%
    Check dated 2026-02-11T09:18:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about government funding affecting site operations was added, and the site version was updated to v3.4.1 while v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T05:15:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI changes include showing the glossary, green and red highlights to indicate additions and deletions, and minor revision notes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T03:28:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Study Record Versions now show addition of revision v3.3.4 and deletion of revision v3.3.3 as part of routine version history maintenance. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:22:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' appears in the Study Record Versions. The footer no longer displays 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T10:18:31.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.